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Abstract: Semiconductor quantum dots (QDs) have served as the basis for signal 
development in a variety of biosensing technologies and in applications using bioprobes. 
The use of QDs as physical platforms to develop biosensors and bioprobes has attracted 
considerable interest. This is largely due to the unique optical properties of QDs that make 
them excellent choices as donors in fluorescence resonance energy transfer (FRET) and well 
suited for optical multiplexing. The large majority of QD-based bioprobe and biosensing 
technologies that have been described operate in bulk solution environments, where selective 
binding events at the surface of QDs are often associated with relatively long periods to reach 
a steady-state signal. An alternative approach to the design of biosensor architectures may be 
provided by a microfluidic system (MFS). A MFS is able to integrate chemical and 
biological processes into a single platform and allows for manipulation of flow conditions 
to achieve, by sample transport and mixing, reaction rates that are not entirely diffusion 
controlled. Integrating assays in a MFS provides numerous additional advantages, which 
include the use of very small amounts of reagents and samples, possible sample processing 
before detection, ultra-high sensitivity, high throughput, short analysis time, and in situ 
monitoring. Herein, a comprehensive review is provided that addresses the key concepts and 
applications of QD-based microfluidic biosensors with an added emphasis on how this 
combination of technologies provides for innovations in bioassay designs. Examples from 




the literature are used to highlight the many advantages of biosensing in a MFS and illustrate 
the versatility that such a platform offers in the design strategy. 
Keywords: biosensor; quantum dots; microfluidics; fluorescence resonance energy 
transfer; immobilization; nucleic acids; multiplexing; diagnostics; biomarkers 
 
1. Introduction 
The engineering of nanomaterials for use in selective sensing has emerged as one of the most 
powerful tools for the development of assays based on optical detection. More specifically, the 
development of fluorescent materials such as semiconductor quantum dots (QDs) has stimulated 
introduction of a variety of bioassay technologies that offer significant advantages over those that have 
previously relied on conventional organic fluorophores. The use of QDs as the basis for a biosensor— 
a tool for the reversible detection and/or quantification of an analyte using biomolecular specificity in 
combination with a physiochemical transducer—has attracted considerable interest due to the unique 
optical properties of such colloidal semiconductor nanoparticles, e.g., high quantum yields, broad 
absorption spectra, narrow and symmetric size-tunable photoluminescent emission spectra,   
relatively long fluorescent lifetimes, and exceptional photostability with a strong resistance to   
photobleaching [1-4]. The optoelectronic characteristics of QDs arise through the systematic 
transformation in the density distribution of the electronic energy levels as a function of the size of the 
QD, a phenomenon known as the quantum confinement effect [5]. As a result, the nature of the QD 
surface plays a key role in the optical behavior of the QDs. Thus, the ability to modify the surface  
of QDs with biomolecules or other moieties through various conjugation methods underpins   
their versatility. 
QD-based biosensors have been incorporated into various applications, often focusing on use of  
the distance dependence of fluorescence resonance energy transfer (FRET) [6,7], and multiple colors 
for multiplexed bioanalysis [8,9], for applications such as immunoassays [10,11], nucleic acid 
detection [12,13], clinical/diagnostic assays [14-16], and cellular labeling and analysis [17,18]. Most 
reports of such QD-based biosensing technologies are reliant on diffusion-limited solid/liquid interface 
reactions as typically found in bulk solution. Various types of assays have been demonstrated in bulk 
solution and on solid substrates such as microbeads and optical fibers [13,19]. Solution-based assays 
using suitably modified QDs can be challenging because of the need to maintain colloidal stability, 
which can limit the type and number of biomolecules that can be conjugated to a single QD. 
Immobilization of such modified QDs at an interface can alleviate this requirement and offers greater 
versatility in conjugation strategies. However, solid-phase assays often require a significant amount of 
reagent for immobilization (similar to that used for solution-based assays), and typically suffer from 
reduced reaction kinetics due to limitations imposed by reliance on interfacial diffusion. Thus, a more 
competitive technology can be obtained by implementing an assay within a microfluidic system   
(MFS), where extremely small (i.e., 10
−9 to 10
−18 liters) quantities of fluid are transported through 
microfabricated channels [20]. MFSs can be used to build surface structures on channel walls through 




recognition. QD bioprobes can be immobilized on channel walls using microfluidic flow conditions, 
and this same platform then allows for the introduction, manipulation, and handling of multiple 
analytical samples in sequence, and opportunity for further removal and replacement of QD-based 
sensing components [21]. Microfluidic technologies offer a number of useful advantages that include: 
the use of extremely small amounts of reagents and samples; ultra-high sensitivity; high throughput; 
possible sample processing before detection; short analysis time; in situ monitoring; and low   
cost [20-22]. The large surface area-to-volume ratio and mass transport by non-diffusive means offers 
the potential for transduction of analytes within seconds to minutes. Microfluidics offers a robust 
platform and excellent portability, making such assays suitable for point-of-care (POC) diagnostics.  
In this review, the convergence of nano- and microtechnologies (e.g., QDs and MFSs) are 
considered and examples from the literature are introduced to illustrate how mounting assays within a 
MFS can develop and/or improve biosensing performance. This review will primarily focus on two 
perspectives: (1) the construction of QD-bioprobes by means of MFS technologies (i.e., synthesis of 
QDs, immobilization of QDs, and derivatization of QDs in situ); and (2) the implementation of a MFS 
to build rapid clinical/diagnostic technologies (i.e., the use of immobilized QDs for target nucleic acid 
detection, multiplexed detection of biomarkers, and manipulation of cells for exposure to QDs). For 
the purposes of this review, the design process centralizes around QDs acting as an integrated sensing 
component in the MFS, concomitantly having an active part in transduction and serving as a 
multifunctional nanoscaffold for biorecognition [23,24]. Some examples of assays where QDs serve 
only as a label are also introduced and represent the simplest integration of QDs for biosensor and 
bioassay design. 
2. Microfluidic Systems for Biosensing 
Microfluidics can be defined as an area of science and technology involving systems based on 
microfabricated structures with the capability to precisely control and manipulate fluids constrained to 
a small scale [20]. As a technology, microfluidics is a multidisciplinary field incorporating chemistry, 
engineering, physics, molecular biology, and microelectronics. Microfluidics has gained significant 
attention within the scientific community because it offers many physical advantages, which are 
specific to their application, when compared to the conventional macro- and meso-scale systems that 
are in common use. A major driving force behind the rapid development of MFSs is the inherent 
potential of this technology to be used in biological applications such as biosensing, a topic that has 
been thoroughly reviewed elsewhere [22,25-27]. MFSs are primed to be a powerful tool for biosensing 
providing the basis for detection and analysis of biomolecules in a simple yet versatile manner [22].  
MFSs normally consist of microscale fluid components and regulators (e.g., pumps, valves, and 
mixers) integrated into a lab-on-a-chip platform that typically includes a component for signal 
transduction. The integration capabilities offered by microfluidics allow for the possibility of an 
extended range of individual laboratory protocols, which include the handling of sample materials, 
chemical reaction, separation, and detection, to be incorporated and automated within the MFS [25]. 
With all of these components set in place, a complete MFS functions to greatly enhance the analytical 
performance of the chemical process from start to finish. A more in depth look at how these 




review. To further examine the intricacies of microfluidics, the scope of this technology is subdivided 
into three paradigms pertaining to the specific platform used to carry out the manipulation of fluids at 
the microscale level. These three paradigms are as follows: (1) continuous-flow; (2) droplet-based; and 
(3) digital microfluidics. A comparison of these methods is summarized in Table 1. 
Table 1. List of three different platforms in the field of microfluidics, including their 








Use of micron sized channels to 
manipulate fluids in series 
Emulsion droplets generated  
by capillary instability [28] 
between immiscible phases and 
confined within a microfluidic 
channel [29,30] 
Manipulation of droplets using a 
patterned array of electrodes [31] 
Flow Actuation 
Pressure driven or  
electrokinetic flow 
Pressure driven flow  External electric field 
Advantages 
Suitable for performing 
separations; surface can be 
chemically modified for grafting 
a biomolecular recognition 
element and control surface 
properties for the manipulation 
of electrokinetic flows, suitable 
for biosensing purposes 
Each droplet can serve as a 
microreactor to perform 
synthesis and study reaction 
kinetics, thus providing an 
opportunity to confine reagents; 
avoid mixing and reagent cross 
contamination problems 
provided that mass transport 
between the droplet and external 
phase can be controlled 
Ability to address each droplet 
individually [32], thus avoiding 
unwanted cross contamination 
between reagents; useful for 
tasks involving sequential 
treatment steps [33] 
Disadvantages 
Unwanted cross talk between 
different reagents is unavoidable; 
managing multiple reagents with 
precise control over their 
position and reaction time  
is complex 
Unable to address each droplet 
individually as they are 
controlled in series [32]; 
encapsulated molecular species 
can partition themselves between 
two phases, thus not compatible 
with all the reagents as this will 
lead to sample losses; issues 
achieving a high degree  
of monodispersity 
Not suitable for electrophoretic 
separations [34]; non-specific 
adsorption can cause 
complications [35]; device 
fabrication requires clean room 
facility; limited substrate 
choices, thereby limiting the 
choice of chemistries to modify 
the surface 
Applications 
Dielectrophoretic separation of 
cells [36], separations involving 
capillary zone electrophoresis 
(CZE), capillary gel 
electrophoresis (CGE), 
polymerase chain reaction 
(PCR), and DNA analyses [37] 
Studies of reaction kinetics [38], 
electroporation of cells [39], 
biological assays [40,41] 
Organic synthesis [42], 
biological assays [43], sample 
manipulation associated with 
proteomics research  




3. Synthesis of Quantum Dots and Subsequent Functionalization 
Semiconductor QDs exhibit a multitude of size-, shape-, and structure-dependent chemical and 
physical properties. Maintenance of the reproducibility of desirable characteristics requires that the 
synthesis of QDs be conducted in a quality-assured system that enables both kinetic and 
thermodynamic control of reaction conditions [45]. Conventional methods for the synthesis of QDs 
rely on high-temperature solution-based reactions derived from organometallic and chalcogenide 
precursors, which are capped with hydrophobic organic ligands [1,46-48]; however, these synthetic 
methods are typically complex and often prove difficult in obtaining reproducible high-quality QDs of 
well-defined size and shape. To address this issue, various research groups have shifted towards   
the use of a microfluidic approach. This technique has been successfully applied to the synthesis   
of multiple QD chemistries—CdS [49,50], CdSe [51-53], InP [54,55], along with more complex 
core/shell structures such as CdSe/ZnS [56,57]. In this section, we discuss the recent developments of 
incorporating microfluidic technologies into the synthesis of QDs and modification thereof, while 
addressing both the advantages and challenges that remain in forming bare or functionalized 
nanoparticles within well-defined microfluidic channels. The interested reader is referred to other 
reviews for a complete summary about the microfluidic synthesis of QDs [45,58]. Throughout this 
review, the notation QDx is used to indicate the QD photoluminescence (PL) peak position at x nm. 
Moreover, the reader should assume that the QD is composed of a CdSe/ZnS (core/shell) material 
unless otherwise stated. 
The majority of continuous-flow microreactors that are used in the synthesis of QDs are divided 
into two general types of systems: (1) capillary-based; and (2) chip-based (Figure 1). The capillary-based 
system represents a simpler method of microfluidic QD synthesis; a set-up requiring only a single 
length of narrow tubing partially immersed in a heated oil-bath with fluid flow driven by pressure. 
Glass and polytetrafluoroethylene (PTFE), both of which are chemically inert and acclimated for high 
temperature procedures, are the materials generally used for the capillary-based system. The second 
type of system uses a solid platform, otherwise known as a “chip”, which contains the microfluidic 
channels internally. These chips can be fabricated from a number of materials, which include glass, 
plastic, silicon, and other polymers. One polymer in particular—poly(dimethylsiloxane), or PDMS—
has become an extremely popular choice for much of the exploratory research done in   
microfluidics [59,60]. PDMS chips are more commonly used for low temperature synthesis, while 
glass or silicon chips are used for the high temperature reactions due to their chemical and thermal 
durability. Whatever the choice, both capillary- and chip-based MFSs have been able to offer similar 
levels of control of QD properties throughout the synthetic process. 
The study by Edel et al. was one of the first publications that described a synthetic procedure for the 
synthesis of CdS QDs using a continuous-flow MFS [49]. The system was based on distributed mixing 
and demonstrated an improvement in the monodispersity of the QDs that were produced. Thus, a 
combination of miniaturization of the reaction vessel and efficient mixing was able to demonstrate the 
superiority over traditional bulk scale procedures. Sounart et al. then reported the first spatially 
resolved investigation of QD growth during the synthetic process within a MFS [61]. The results 
obtained from synthesizing cysteine-capped CdS QDs suggest a diffusion-limited case based on the 
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makes it harder to formulate precursor materials and often leads to the production of QDs with obdurate 
crystal defects [54,63]. The research team was able to accomplish the synthesis in both chip- and 
capillary-based MFSs by using a reaction of two precursor solutions or a combination thereof, 
respectively. The first precursor contained InCl3, oleic acid, zinc undecylenate—a surface passivation 
agent, and oleylamine in octadecene—a non-coordinating solvent. The second precursor contained  
tris-(trimethylsilyl)phosphine in octadecene. As a result, a process that was once deemed to be a 
significant synthetic challenge became feasible by using a microfluidic approach. More recently,   
Baek et al. were able to accomplish a similar synthesis of InP QDs using a three-stage high-temperature 
and high-pressure MFS consisting of mixing, aging, and sequential injection stages [55]. The main 
objective of the researchers was to investigate the role of free fatty acids (i.e., myristic acid) on 
nanoparticle size. The concentration of free myristic acid was determined to be a major contributing 
factor of the interparticle ripening processes, providing InP QDs with first excitonic absorption peaks 
ranging from 495 nm (absence of free myristic acid) up to 650 nm, corresponding to InP QDs with  
a size of ca. 2 to 4.3 nm in diameter, respectively. 
Further progress that has been made in the use of microfluidic technology includes investigation of 
the surface functionalization of the QDs. Kikkeri et al. used a continuous-flow microreactor to 
synthesize high-quality carbohydrate (e.g., mannose or galactose) and carboxylic acid (dihydrolipoic 
acid, DHLA) functionalized CdSe- and CdTe/ZnS QDs with variable emission peaks in the range  
of 480–598 nm [64]. In this particular case, the MFS was not only used to synthesize the QDs, but also 
to modify the surface with biologically relevant moieties. The full capability of MFSs to functionalize 
QDs has not yet been thoroughly addressed and still requires further investigation. 
It should be clear from the preceding examples that the use of a MFS offers many potential 
advantages in the chemical synthesis of QDs due in large part to the precise control and manipulation 
of the reaction conditions, high throughput, and a safer working environment throughout the synthesis 
process [45,64]. One of the attractive features of the MFS approach is the large surface-to-volume ratio 
provided by the microfluidic channels, which allows for accurate temperature control along with 
efficient mixing of the precursor solutions [64]. The ability to achieve large-scale production of QDs 
becomes possible by parallelization, where numerous microreactors operate in unison, or by 
implementation of a continuous-flow reaction protocol. Continuous-flow MFSs inherently improve 
reproducibility of synthesis and facilitate in situ monitoring [52,53]. Overall, the use of microfluidics 
changes the entire approach to QD synthesis, potentially creating a new standard for quality of   
QD technology. 
4. Quantum Dot-Mediated Fluorescence Resonance Energy Transfer  
Fluorescence continues to be one of the most common methods of detection or quantification for 
various biomolecules [2,65]. More specifically, FRET—the non-radiative energy transfer between an 
excited state fluorophore (donor) and another fluorophore/chromophore (acceptor) through long-range 
dipole-dipole coupling—has become a common detection scheme used in bioanalytical methods to 
monitor binding interactions as well as conformational changes [66,67]. The utility of FRET is unique 
in generating fluorescence signals sensitive to molecular conformation, association, and separation in 




and the acceptor. FRET-based transduction using QDs as donors has become a rather popular approach 
for assay development, in part because enhancements in the FRET efficiency can be achieved as a 
result of the introduction of multiple pathways for energy transfer. A transduction strategy can be 
arranged using immobilized QDs and dyes where many QDs have the opportunity to interact with a 
single acceptor dye, or multiple dyes can interact with a single QD. The enhancement is similar to that 






6   (1) 
where E represents the energy transfer efficiency, n is the number of proximal acceptors, Ro is the 
characteristic Förster distance for the FRET pair at which energy transfer is 50% efficient, and r is the 
distance between the donor and acceptor.  
A detailed description of the advantages of using QDs as donors in FRET for solid-phase assays 
can be found elsewhere [24]. QDs have become increasingly integrated into FRET-based assays, in 
particular as donors, offering a number of advantages, most of which have been explored in a number 
of recent reviews [6,7,24]. In counterpoint, QDs have been shown to be less efficient acceptors when 
used in combination with molecular dye donors in FRET studies [68,69]. QDs have the potential to 
serve as excellent acceptors in chemiluminescence resonance energy transfer (CRET) where no 
excitation source is used [24]. Reasons for this behavior stem from the fact that QDs possess higher 
quantum yields than molecular dyes and have a higher cross-section for the absorption of light. They 
also tend to be more resistant towards photobleaching, allowing for application in long-term assays. 
Another benefit of QDs is their broad absorption spectrum in the UV region, which can be used 
advantageously to avoid the direct excitation of acceptor dyes. Transduction via FRET also enables 
multiple methods for data analyses. Ratiometric detection is often used and easily accounts for 
differences in assay preparation amongst multiple analyses and instrumental drift. The narrow 
symmetric emission profile of QD PL facilitates deconvolution of acceptor signals for recovery of 
absolute signals [70]. This section serves to address the various aspects of FRET that are significant to 
QD-based biosensors and focuses on the integration of QD mediated FRET transduction in MFSs. 
Microfluidics has been known to facilitate single molecule detection (SMD) studies, and the use of 
SMD for QD mediated FRET has also been demonstrated [71]. SMD studies are useful to determine 
patterns and distributions that may otherwise be masked by ensemble averages [72]. SMD studies are 
usually performed by monitoring a fixed volume of solution, more commonly known as the detection 
volume. Traditionally, analytes are allowed to diffuse into this fixed volume in order to be detected. A 
continuous-flow system as found in capillaries and microfluidics ensures that multiple analytes are 
moved across the detection volume, increasing the probability of detection. Zhang et al. made use  
of microscale flow in capillaries to facilitate SMD studies of QD mediated FRET (Figure 2) [73]. A 
QD-DNA bioconjugate was used for these studies and was comprised of 3'-biotinylated nucleic acids 
immobilized onto a streptavidin-QD605. The 5' end of the DNA was further labeled with a Cy5 dye to 
serve as a FRET acceptor. A 488 nm laser was focused onto the center of a 50 µm capillary that 
contained the QD-DNA conjugates. Pressure driven flow was used to drive the sample across the 
detection volume of the laser. Compared to bulk measurements, improved FRET efficiencies were 





























































ow a FRET 
r was calcu
y calculated




















e effect of f


















































































n led to an i
pared to a 
op a sandw
d in bulk s
FRET effic

















































































y5; and   





































symmetric emission spectra with Gaussian-like PL curves, allowing for the simultaneous excitation of 
multiple fluorescence colors at a single excitation wavelength within a given wavelength range and the 
straightforward use of deconvolution schemes to quantitatively resolve individual QD fluorescence 
signals [24,70]. Multiplexed detection capabilities within a MFS was demonstrated by Zhang et al. [76], 
in which two color coincidence detection and FRET was used to analyze two different nucleic acid 
sequences using a single color of QD. The target strand of one DNA was labeled with Alexa Fluor 647 
for FRET-based detection. The other target strand was labeled with Alexa Fluor 488, which could be 
directly excited by a laser at 488 nm. Monitoring the presence of the PL of Alexa Fluor 488 and the 
QD in the same detection volume was indicative of a positive signal for the nucleic acid sequence. The 
ability to immobilize multiple sequences onto a single QD improved the sensitivity of two color 
coincidence detection as it concentrated multiple fluorophores in a small volume. Also, use of capillary 
flow allowed for only a small volume of solution to pass through the detection volume. This reduced 
the coincidence of free labeled nucleic acid with a QD, which would have registered as a positive 
signal in two color coincidence detection. Additional advantages of operating SMD in capillary flow 
are that each molecule is excited only once, thereby reducing the incidence of photobleaching, high 
signal-to-noise ratio, as well as near-zero background noise without interference from background 
fluorescence. However, this comes at a cost of running increased volumes of solution through the 
capillary in order to maintain a sufficient signal-to-noise ratio. Puleo et al. [77] were able to overcome 
this issue by using an integrated closed loop, rotary pump, fabricated with the use of multilayer soft 
lithography. In this design, the microchip consisted of a closed loop, a part of which was interrogated 
by a laser-induced fluorescence (LIF) microscope. The loop could hold approximately 5 nL of 
solution, which was driven through the loop using a set of peristaltic pumps controlled by solenoid 
valves. This allowed the same sample to be analyzed multiple times, resulting in improvement of the 
sensitivity of detection. It was demonstrated that the sensitivity achieved using this device was similar 
to that obtained by continuous-flow capillaries, but a much smaller volume was used. The repeated 
sampling of a single volume of solution could increase the probability of photobleaching, and this was 
also investigated in the study. It was determined that a continuous monitoring time of 400 s produced 
results that were similar to continuously injecting the solution through a regular capillary. At longer 
analysis times, the effect of photobleaching was noticeable. 
For microfluidic-based separations, LIF is a common detection scheme because high sensitivity 
methods are required to measure the small number of molecules in the small volumes of microfluidics. 
An alternative detection method was developed by Zhao et al. [78]. The CRET between luminol and a 
CdTe QD was used to detect various organic compounds of biological interest in solution as they were 
separated by capillary electrophoresis; a technique that has become a major application of 
microfluidics. It was observed that by mixing luminol, mercaptopropionic acid coated QDs, and 
sodium hypobromite, energy transfer could be observed from the luminol to the QD. This energy 
transfer was interrupted by the presence of a number of active groups, such as amines, thiols, organic 
acids, and steroids, in solution. To integrate this system with a MFS, sodium hypobromite was 
introduced at the end of the separation channel and the running buffer contained luminol and the QDs. 
The luminescence of the QD via CRET was monitored at the end of the separation channel. The 
reduction in CRET was used to identify analytes as they eluted from the separation component of the 




common detection schemes. This system was further used to demonstrate the analysis of amino acids 
secreted from a single cell. In this case, a single cell was isolated in a microfluidic channel and was 
subjected to a series of electrical shocks. The separation was then performed on the molecules released 
from the cell, and the analytes were detected by monitoring the inhibition of CRET. The analytes 
detected from the cell were in the attomole/cell range, illustrating the sensitivity of this technique. 
Another use of capillary electrophoresis was demonstrated by Li et al. in which they explored   
FRET-based immunoassays [79]. Mouse immunoglobulin (IgG) was conjugated to a CdTe QD532 that 
served as the FRET donor, while goat anti-mouse IgG was conjugated to a CdSe/ZnS QD632 that 
served as the acceptor. Upon immunoreaction, FRET was observed between the two QDs, providing 
FRET efficiencies of ca. 70%. While it was possible to directly excite the acceptor, capillary 
electrophoresis was used to separate the acceptor QDs that were not bound to the donor QD, thus 
reducing the incidence of false positives. An increase in intensity of the acceptor in the immunocomplex, 
as compared to that of the free QD was observed and attributed to FRET. Thus, the separation 
capability of capillary electrophoresis enabled the use of QDs as both the donor and acceptor, 
providing for a sensitive and versatile analysis method. 
Another important property of flow achieved by moving to a microchannel scale is a low Reynolds 
number. A laminar flow regime is in place for low Reynolds number, and this typically provides for 
diffusion-limited reactions (in flat planar channels). This property is useful in the study of the kinetics 
with regards to various processes. Ho et al. [80] were able to demonstrate the use of a T-channel 
microfluidic structure to determine the complexation kinetics of plasmid DNA with chitosan, a 
cationic polymer with favourable properties for gene delivery. The plasmid DNA was conjugated to 
streptavidin-QD605 bioconjugates via a biotin label, and the chitosan was partially labeled with Cy5 to 
serve as a FRET acceptor. By introducing these solutions simultaneously through a T channel, 
complex formation initially occurred only at the physical interface of the two streams of solution. The 
resulting FRET signal was used to monitor complex formation between the DNA and chitosan. In this  
system, the temporal resolution of the reaction became spatially resolved along the length of the 
microchannel. Simplification of kinetic studies was achieved by imaging of the entire channel and 
providing for real-time monitoring. In addition, the laminar flow regime allowed the diffusion 
coefficients of the complexes to be determined, which provided information about the size of the 
complexes as they formed. The results obtained were corroborated by physical measurements made 
using electron microscopy [81]. 
5. Strategies for Immobilization of Quantum Dots and Quantum Dot-Bioconjugates 
Solid-phase assays are becoming an increasingly popular approach in the development of 
biosensors that integrate QDs. Immobilization of QDs at an interface offers numerous advantages with 
respect to solution-based analyses. Most importantly, the necessity to maintain colloidal stability, 
which can often at times impose limitations or influence the performance of an assay, no longer 
becomes a requirement. This provides the opportunity to conduct analyses in complex matrices of 
varying pH or ionic strength [24]. One such example occurs in the case of thiol-alkylcarboxylic acid 
coated QDs. These typically require that the pH of the solution be kept alkaline and low in ionic 




hybridization are more efficient at neutral pH and at higher ionic strength to screen backbone 
phosphate charge. Interfacial immobilization of QDs permits analyses at solution conditions that are 
conducive to hybridization without concern for colloidal stability. Immobilization also simplifies 
washing and/or extraction procedures, facilitating the removal of adsorbed material and increasing 
stringency conditions. In a microfluidic channel, regeneration and reusability of the sensing surface 
can be readily achieved if biorecognition is a reversible process. From a practical perspective, it is also 
the case that immobilization onto solid supports minimizes any loss of QDs into the environment [19]. 
These advantages enable the development of stable and regenerable QD-based biosensors with 
improved sensitivity and rapid response. 
The interfacial immobilization of QDs for biosensing applications requires consideration of 
stability, immobilization density, and compatibility for subsequent biomolecule conjugation [24]. The 
latter is often the most important consideration, largely because the surface of the QD must be 
activated with ligands that are suitable for both immobilization and possible subsequent ligation. The 
size and orientation of the biomolecule are further factors that impact on assay performance and are 
often influenced by the coupling method. Progress that has been made in preparation of QDs with 
novel surface ligands, as well as availability of coupling chemistries that provide orthogonal functional 
groups to common biological groups (e.g., −SH, −OH, −CHO, −COOH, −NH2), in combination allow 
for significant flexibility in regards to the methods that can be chosen for immobilization and 
bioconjugation. Coordinate/dative bonds, physical entrapment, passive adsorption, layer-by-layer 
assembly (LbL), and bioaffinity-mediated interactions are just some examples of the more commonly 
used immobilization strategies. 
In MFSs, two opportunities exist for immobilization: (1) coupling to the interior channel   
walls; mainly the glass component, although methods for the derivatization of PDMS have also been 
reported [82]; and (2) use of pseudo-stationary phases that can be introduced into channels such as 
polymeric or magnetic microbeads (Table 2). 
Table 2. Examples of in-channel and microbead immobilization of QDs. 
Immobilization Method 
Solid-phase Support 



















5.1. In-Channel Assays 
Interfacial immobilization of QDs has been adopted in many on-chip solid-phase assays for the 
detection of a wide variety of analytes. Our research group has developed in-channel QD-FRET based 
assays for the detection of nucleic acids using various immobilization strategies [21,85,87]. For 
example, streptavidin-coated QD525 conjugates were immobilized to a biotin functionalized glass slide. 




oligonucleotides and then subjected to Cy3 labeled complementary and non-complementary targets. 
Delivery of QDs, probes, and target nucleic acids were accomplished in-channel, with the former being 
facilitated by electro-osmotic flow (EOF) and the translocation of oligonucleotides by electrophoresis. 
Hybridization provided the necessary proximity for FRET between the QD and Cy3 labeled 
oligonucleotides [87]. The assay displayed excellent resistance to non-specific adsorption, which was 
ascribed to the streptavidin coating on the QDs. The drawback in this design was the limited sensitivity 
of the assay. This was attributed to the intrinsic size of the streptavidin-QD conjugates, where the 
protein dimensions (5.6 × 5.0 × 4.0 nm) [94] and a polyethylene glycol (PEG) tether significantly 
contributed to a large QD-Cy3 separation distance. FRET efficiencies determined by time-resolved 
fluorescence measurements of less than 20% were reported. In an unrelated design, transduction of 
nucleic acid hybridization was demonstrated in a reusable format where the sensing surface could be 
regenerated for multiple cycles of analysis. In this assay, 3-mercaptopropionic acid (MPA) 
functionalized QD525 were concurrently conjugated with two different nucleic acid sequences via   
self-assembly through a terminal thiol. One sequence served to hybridize with a complementary probe 
oligonucleotide that was immobilized on the glass slide of a microchannel within a PDMS-glass chip. 
The other sequence served to transduce hybridization via FRET sensitized emission from Cy3 labeled 
targets. Immobilized QDs could be removed by duplex destabilization by increasing the applied 
voltage, resulting in a combination of shear force and Joule heating leading to dehybridization. It was 
demonstrated that destabilization of hybrids could also be achieved by the addition of formamide into 
the running buffer. Multiple cycles of regeneration were possible as new QD-oligonucleotide 
conjugates could be delivered electrophoretically to the areas of the glass channel that were coated 
with immobilized nucleic acid [21]. The results of the chip-based assay compared favorably to those 
obtained from previously developed solid-phase assays [19] on optical fibers. Our research group has 
also used microfluidics to develop a QD-FRET based assay with improved FRET efficiency and 
enhanced sensitivity. In this work, transduction of nucleic acid hybridization was demonstrated in two 
separate FRET pairs: (1) QD625 paired with Alexa Fluor 647; and (2) QD525 paired with Cy3 (Figure 3). 
Interfacial immobilization of QDs was facilitated by ligand exchange of the MPA coating of the QD 
with multidentate surface ligands as previously developed [95]. Subsequent conjugation of 
immobilized QDs with amine terminated nucleic acid probes was accomplished through activation  
of the remaining MPA surface ligands with N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide (EDC) 
and N-hydroxysulfosuccinimide (NHS). The remaining surface sites of the immobilized QDs were 
passivated with unlabeled oligonucleotides, which have shown the ability to adsorb strongly onto the 
surface of MPA functionalized QDs [96]. Hybridization with complementary targets generated FRET 
sensitized Cy3 or A647 fluorescence with improved FRET efficiencies in comparison to assays that 
used streptavidin-QDs. Excellent selectivity was also achieved against non-complementary labeled 
targets [85]. This preliminary work is the prelude for the development of a multiplexed color assay 
capable of the concurrent detection of two nucleic acid targets. An important advantage of integrating 
these assays into an electrokinetically controlled MFS is that it allows for rapid in-channel assay 
assembly with minimal sample reagent consumption. An electrokinetically controlled environment has 
also been previously reported to enhance the stringency of nucleic acid hybridization, where elevated 
voltages can shear fully complementary duplexes for assay regeneration [21,97] and can even allow 
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wavelength [100]. Microbeads also facilitate diffusional mixing in laminar flow regimes, which can 
greatly enhance the efficiency of an assay. Magnetic beads provide biocompatibility and the ability for 
ease of isolation by use of an external magnet [91]. This permits routine washing or extraction steps, 
which can greatly enhance the performance of an assay without the need to be concerned about 
substrate stability. The following section describes examples of bioassays that integrate polymeric or 
magnetic beads into the design. 
Immunoaffinity is a popular choice for introduction of selectivity in bead-based assays because 
various chemically modified polymeric beads can be readily coupled with antibodies. It is also possible 
in some cases to use passive adsorption on polymeric materials to facilitate the immobilization process. 
Yun et al. have developed a QD-bead based immunoassay that uses a MFS capable of single bead 
isolation and interrogation [92]. Streptavidin-coated, 10 µm polystyrene beads were derivatized with 
biotinylated protein-A and delivered into a PDMS-glass microfluidic chip. On-chip single bead 
isolation was facilitated by use of a pneumatically controlled micro-chamber integrated into the PDMS 
layer. The 50 µm × 50 µm × 30 µm chamber consisted of two gates that were controlled by channels 
imprinted in and above the PDMS layer. Upon application of vacuum to either channel, each gate 
could rise and allow a micro-bead to enter the chamber. In the closed position, each gate did not 
completely seal the channel. A small gap permitted the flow of solution but prevented beads from 
entering or leaving the chamber. Sequestered beads were then further conjugated with human   
IgG antibody. Anti-human IgG-QD conjugates were subsequently delivered into the chamber and 
captured by the IgG conjugated bead. Antibody detection was facilitated by the fluorescence of QD605 
upon excitation from a 470 nm source. Fluorescence images of isolated beads were captured using a 
charge-coupled device (CCD) camera. A LOD of 0.1 µg/mL was reported for the antibody [92]. A 
multiplexed QD-microsphere immunoassay was reported by Lucas et al. [93], in which highly 
carboxylated polystyrene-polyacrylic acid latex beads were coated with amino-PEG QDs via passive 
adsorption. The authors referred to these configurations as nano-on-micro (NOM) moieties. 
Specifically, two NOM moieties were designed in this assay: NOM-605 and NOM-655, where 605  
and 655 refers to the PL max of the immobilized QDs. NOM-605 and 655 were then conjugated with 
bovine serum albumin (BSA) and mouse IgG, respectively. Varying concentrations of anti-BSA,   
anti-mouse IgG or equal mixtures of the two were then introduced and antibody capture resulted in 
agglutination of the microbeads. Detection was facilitated by coupling the output of a 380 nm   
light-emitting diode (LED) into the channel via an optical fiber and positioning the detection fiber at  
a 45° angle relative to the source. Aggregation of the NOM(s) caused an increase in the scatter of 
source photons, which identified the presence of antibody. The decrease in PL from either QD605 or 
QD655 signified whether the antibody was anti-BSA or anti-mouse IgG, respectively. Selective 
detection of each individual antibody was demonstrated, and a LOD of 100 ng/mL was reported for the 
scatter response. A LOD of 200 ng/mL was obtained for transduction via decrease in QD PL. The 
system was also subjected to simultaneous exposure of equimolar amounts of the antibodies in both a 
two-well plate and on-chip formats. The assay demonstrated multiplexed detection and provided a 
LOD of the total antibody concentration of 50 ng/mL from light scatter [93]. Aptamer-based 
recognition for the detection of thrombin was demonstrated using a sandwich assay format with 
magnetic beads and QDs [91]. The assay was conducted using a novel chip design that used eight 




connected to a syringe pump to remove solution from the chip after each washing step. Streptavidin 
functionalized beads and QDs were conjugated to two DNA thrombin-binding aptamers, each 
recognizing separate epitopes of the protein. The aptamer bioconjugated beads were fixed in each 
reservoir by external magnets under the chip. Various concentrations of thrombin were added to each 
reaction reservoir followed by washing steps and then addition of the aptamer coated QDs. Chips were 
then imaged using fluorescence microscopy, and QD PL was used to transduce thrombin recognition. 
The dynamic range of the assay was reported to be 100–1,000 ng/mL and the LOD was determined to 
be 10 ng/mL. The selectivity of the assay was demonstrated using an aptamer that was non-specific for 
thrombin, a 700-fold excess of human serum albumin (HSA) and 72 µg/mL of prothrombin. In all 
cases, no appreciable fluorescence was detected above the signal obtained from the controls. The  
chip-based results were compared to an assay conducted in a 96-well plate, which displayed similar 
performance. However, the on-chip analysis was considered to have the favorable advantages of 
automation, increased assay efficiency, and the opportunity to operate in a multiplexed format [91]. 
Jokerst et al. [101] reported the use of a QD-based MFS for the multiplexed detection of various 
biomarkers for clinical/diagnostic application based on a microsphere bead support. In this example, 
QDs functioned as detection elements for the multiplexed quantification of three cancer biomarkers: 
CEA—colon cancer, cancer antigen 125 (CA125)—ovarian cancer, and human epidermal growth 
factor receptor 2 (Her-2)—breast cancer. The authors were able to exploit the optical properties of 
QDs to provide useful quantitative cancer biomarker information using both serum and whole saliva 
clinical samples. The QD-based MFS made use of a typical sandwich immunoassay approach, where 
agarose beads served as a solid-phase support structure for capture antibody immobilization. The three 
analytes provided linear dose responses ranging from 0–100 ng/mL, 0–60 ng/mL, and 0–400 U/mL for 
CEA, Her-2, and CA125, respectively. The LOD for CEA and Her-2 were 0.02 ng/mL and 0.27 ng/mL, 
respectively, with no LOD given for CA125. More specifically, the system proved to be almost twice 
as sensitive to that of an ELISA assay and demonstrated the advantages of combining QDs and a MFS 
to obtain high intensity signals, low LODs, and short assay times. 
The use of QD encoded beads integrated into a MFS to perform low volume multiplexed assays 
was demonstrated by Riegger et al. [90] in a duplex sandwich immunoassay. They used two sets  
of 150 µm polystyrene beads, each set encoded with a single color of QD. The beads were 
functionalized with the antigen for hepatitis A and tetanus, allowing the antibodies for these infectious 
diseases to bind to the bead. The presence of antibodies was then transduced by a labeled detection 
antibody. A centrifugal microfluidic device was used for the various sample handling steps such as 
reagent delivery and washing steps. An imaging-based detection system was used to facilitate the 
detection of all beads simultaneously. To ensure that all beads were imaged, the beads were packed 
into a monolayer using a chamber that had a height slightly larger than the beads. To facilitate 
portability, a high-power 475 nm LED was used for excitation of all QDs and the assay label, and a 
color CCD-camera was used for detection. FluoSpheres
®, which are beads packed with organic dye 
molecules, were used as the assay label due to the high sensitivity offered. Using an incubation time of 
only 180 s and washing time of 20 s, LODs of 215 mIU/mL and 158 mIU/mL were obtained for the 
hepatitis A assay and the tetanus assay, respectively. While the imaging detection module has the 




be analyzed. Any inhomogeneity in the image would affect the data obtained, as was observed in the 
experiment due to the fact that the interior of the beads were not uniformly packed with QDs. 
Another common approach for analyzing encoded beads is the analysis of single beads in a flow 
stream with the use of a flow cytometer. This has the advantage of spectral-based bead detection, 
which is not affected by the spatial distribution of dye inside the bead. In addition, a larger number of 
beads may be analyzed and is limited only by the detection instrumentation. Microfluidics can be used 
instead of a flow cytometer [102], as was demonstrated by Klostranec et al. in the use of a MFS  
for multiplexed assays using QD encoded beads [89]. A triplex immunoassay for infectious diseases 
(i.e., human immunodeficiency virus (HIV), hepatitis B, and hepatitis C) was performed using three 
sets of beads that were labeled with varying combinations of two colors of QDs (Figure 5). The 
antigens were immobilized on the surface of the microbeads and incubated with sample solutions to 
bind labeled antibodies. Subsequently, the beads were washed and introduced into the microfluidic 
device. The microfluidic device made use of focusing by electrokinetic flow to ensure that the beads 
crossed the detection volume in single file allowing for single bead detection. In electrokinetic 
focusing, the sample stream is sandwiched between two streams known as the sheath flow, with all 
streams intersecting at 90° to each other. Mixing of the three streams is avoided due to the laminar 
flow regime of microfluidics [103]. A laser at 488 nm was focused onto a certain spot in the 
microchannel and was used to excite the QDs as well as the fluorophore conjugated to the detection 
antibody. The emitted fluorescence was simultaneously detected using a PIN photodiode for green 
wavelengths, and an avalanche photodiode for the yellow and red bandwidths. Using this detection 
system, the instrument could analyze 70 beads per minute. Focusing by use of electrokinetic flow 
allowed the facile control of sample stream width, involving only adjustment of the voltage applied 
across the different microchannels. In addition, the use of a sheath flow prevented direct contact with 
channel walls reducing any non-specific interactions. The use of electrokinetic controlled flow rather 
than pressure driven flow makes the instrumentation more compact, and the complexity of the system 
is further reduced with the use of QDs. The MFS completed the analysis of three infectious diseases in 
less than an hour, using less than 100 µL of sample and was found to be 50 times more sensitive than 
FDA approved methods. 
An alternative to incorporating QDs inside a bead is to immobilize the labels onto the surface  
for purposes of encoding. This offers simplification for bead encoding. The use of this approach for a 
two-plex immunoassay was demonstrated by Ma et al. [88]. Two different colors of QDs were 
immobilized onto a microbead using the LbL approach, and the ratio of the two colors were used for 
encoding beads. A PEM consisting of positively charged polymer (poly(allylamine hydrochloride)) 
and negatively charged polymer (poly(styrene sulfonate)) was immobilized along with the QDs, with 
different colors of QD occupying different layers. This placed a restriction on the intensity ratios that 
were possible because lower layers of QDs were found to have a lower intensity once a layer of QDs was 
immobilized on top. The outermost layer of the bead was used for the immobilization of the capture 
antibodies. These beads were used for a proof of concept immunoassay to detect human IgG and rabbit 
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An LIF system was used for detection, and a 488 nm laser was the single source of excitation of the 
QDs and the fluorescein isothiocyanate (FITC) conjugated detection antibodies. The scatter of the laser 
was also used to verify the presence of a bead. The use of microfluidics facilitated single bead analysis 
using coincident detection applied to four channels of information. One channel used the scatter of light 
from the beads to register the presence of a bead in the flow stream. Two channels of luminescence 
from the dots were used to decode the bead. The remaining channel was used to monitor the 
luminescence intensity of the dye conjugated detection antibody.  
The above examples serve to demonstrate the advantages of using microfluidics for bead-based 
assays that use QDs either as a label for the detection of biomolecules or as an encoding mechanism 
for solution phase multiplexed assays. The novel chip design strategies incorporated into these assays 
serve to enhance their analytical performance by providing a method for routine bead manipulation, 
less intensive extraction and washing steps, and facile automation. 
6. Cellular Analysis 
Cell analysis and processing has greatly benefited from the field of microfluidics, where similarities 
between the dimensions of cells and microchannels (10–100 µm) are able to facilitate spatial and 
temporal manipulation of cells and their microenvironment. Flow focusing [104], electroporation [105], 
dielectrophoresis [106], and cell lysis [107] are just some of the routine procedures that can be 
conducted rapidly and with excellent precision using microscale phenomena. Flow focusing and cell 
trapping can be used to interrogate single cells individually [108]. Electric field driven phenomena 
such as electroporation can be used to actively deliver reagents like DNA or QDs into cells [109], 
while dielectrophoresis can be used to perform on chip separation of transformed cells from those that 
remain unaffected. In addition, dielectrophoresis provides the capability of segregating live cells from 
dead cells [110]. Electrokinetic phenomena can also be used to lyse cells for subsequent analysis of 
their content and to perform on chip flow cytometry. All of these tasks can be integrated within a 
single microfluidic chip to develop a micro total analysis system (µTAS) [111,112]. Once again, the 
increased surface area-to-volume ratio associated with microfluidic channels becomes advantageous 
by allowing for fast analysis time, which is due in part to the enhanced mass transport effect [113,114]. 
Additionally, since cells are confined to nL-pL volumes within microchannels, the concentration of 
analyte does not become too dilute for detection. For this reason, MFSs have been used to study a 
variety of cellular responses, including cell differentiation [115], chemotaxis [116], and gene 
expression [117]. The integration of nanotechnology and cellular studies using a MFS has unarguably 
facilitated many possibilities in which nanotechnology can be applied to cellular studies.  
Development strategies to deliver QDs intracellularly to their biological targets (i.e., mitochondria, 
endoplasmic reticulum, and nucleus) with high efficiency and selectively enables QDs to serve as 
labels for monitoring intracellular protein trafficking in terms of their spatial and temporal activity as 
well as other QD-cellular applications such as imaging and in vivo sensing. Effective delivery and 
targeting is critical to better understand the many complex intracellular signaling and gene regulation 
pathways. Such analyses will ultimately provide much insight into the development of therapeutics 
that can efficiently target and modulate intracellular pathways for disease prevention [118]. One of  




cells [119,120]. Ideal characteristics of a delivery method should include: limited incubation time of 
cells with QDs in order to minimize cytotoxicity, reduction of the perturbation of cellular function, and 
prevention of the accumulation of introduced QDs into one specific organelle.  
It has been proven that the ultimate fate of QDs within a cell is a function of the delivery method 
and the QD surface chemistry. The choice of introduction method will in part be a function of the 
desired application for the intracellular QDs. Targeted delivery of QDs will require a combination of 
facilitated and active delivery methods which direct QDs to a particular organelle and bypass the 
endosomal system of the cells. If only intracellular labeling is required, then passive and facilitated 
methods can be used for delivery. However, diagnostic applications and intracellular monitoring will 
require that the monodispersity of QDs be maintained, therefore, microinjection may be a more 
suitable option. Microfluidics clearly provides a state-of-the-art technology for the handling of QDs 
and cells, where multiple functions (i.e., surface modification of QDs with nucleic acids, antibodies or 
peptides for facilitated delivery or intracellular sensing, electroporation of cells with QDs, cell sorting, 
dielectrophoretic separation of live and dead cells, and cell lysis) can be integrated within a single chip 
to provide a POC biosensor system. 
The study conducted by Zhao et al. used QDs conjugated with Annexin V—a cellular protein  
that binds with the phosphatidylserine moieties in the plasma membrane of apoptotic cells—to   
screen for anti-cancer drugs. A MFS was implemented to analyze cell apoptosis at a single cell level 
(Figure 6) [121]. Analysis of apoptosis in microfluidics offers advantages such as real-time 
monitoring, which assists in the evaluation of the effect of cell heterogeneity on cell apoptosis, and 
provides rapid transduction by reducing the diffusion time of QD-Annexin V conjugates. Ultimately, 
these capabilities are unmatched by the conventional techniques used for studying cell apoptosis. The 
MFS used by Zhao and co-workers to study cell apoptosis incorporated a concentration gradient 
generator reported by Dertinger et al. [122]. It consisted of nodes and serpentine-like channels 
designed to split the initial stream of fluid into multiple channels, where a dilution step at the branch 
point was used to manipulate the composition of the starting solution at the inlet reservoir. The 
concentration gradient generator allowed for the interrogation of anti-cancer drug potency at various 
levels. In addition, the microfluidic network incorporated microstructures consisting of “sand-bag” 
dam structures to dock single cells [123,124] by applying an appropriate lateral pressure in the cell 
culture chambers. The effect of three anti-cancer drugs (e.g., cycloheximide, etoposide, and 
camptothecin) on cell apoptosis was considered in this study (Figure 6). The percentage of cells 
showing apoptosis were found to be proportional to the concentration and incubation time with the 
particular anti-cancer drug. In addition, it was found that camptothecin was the most potent of the three 
drugs investigated in terms of inducing cell apoptosis. 
Zhang and co-workers performed fluorescence in situ hybridization (FISH) and QD-labeled 
immunofluorescent assay for the rapid detection of viable and non-viable microbial cells in a 
microfluidic device [125]. The device structure incorporated a filtering chamber consisting of trapping 
pillars separated by a distance of 1–2 micrometers for the isolation and concentration of microbial cells 
(Giardia lamblia). The advantage of performing an immunofluorescent assay in a microfluidic 
environment is the speed of analysis (i.e., within minutes) due to enhanced mass transport, where 
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Morarka et al. developed a microfluidic-based immunosensing platform for the rapid detection of 
Escherichia coli (E. coli) using QD-antibody (anti-E. coli) conjugates as labels [126]. E. coli cells were 
adsorbed to the surface of the plasma oxidized PDMS microfluidic walls followed by the injection of 
QD-antibody conjugates through use of capillary action. The fluorescence intensity from the   
QD-antibody conjugates was found to be proportional to the concentration of cells in the sample. The 
drawback of this immunosensing approach was that the antigens (i.e., E. coli cells) were captured 
along the length of the microfluidic channel by non-specific means, hence, requiring long incubation 
times for capture by antibody. Additionally, the reproducibility of the signal response was expected to 
be poor due to the continual washing of cells and antigen-antibody conjugates by continuous-flow.  
In order to identify the potential of QDs as suitable substrates for in vivo applications, it is 
important to evaluate the factors that govern the cytotoxicity of QDs. Such studies will help elucidate 
and provide helpful insight into the criteria needed for consideration in the design of QD-based 
intracellular probes. Mahto et al. investigated the cytotoxic effects of MPA and cetyltrimethylammonium 
bromide/trioctylphosphine oxide (CTAB/TOPO) functionalized QDs on neuron-like PC12 cells using 
a compartmentalized microfluidic device consisting of two straight channels connected by 
microgrooves [127]. This channel network provided for the isolation of axons from their cell body, 
enabling localized exposure of QDs to axons and the cell body. The results suggested that the stability 
of a ligand on the surface of a QD plays an important role in maintaining cell viability. Concentrations 
as low as 0.427 nM of CTAB/TOPO-QDs showed significant signs of cytotoxicity within 2 h, directly 
causing morphological changes, cell shrinkage, degenerated axons, and loss of cell adhesion. On the 
contrary, 1.0 nM concentration of MPA-QDs showed no signs of cytotoxicity even after 6 h of 
exposure. Also, only the CTAB/TOPO-QDs showed signs of axonal degeneration caused by the 
potential involvement of reactive oxygen species upon preferential exposure to axons, while the cell 
body was found to be healthy. Mahto et al. also investigated the cytotoxic effects of CTAB/TOPO 
modified CdSe/ZnSe QDs on BALB/3T3 fibroblast cells studied under flow exposure conditions using 
a microfluidic device and compared the results with static exposure conditions using a well-plate 
system [128]. The microfluidic network used for the flow exposure conditions was based on two inlet 
reservoirs that merged into one main channel, where the main channel subsequently diverged into ten 
parallel channels. It was suggested that flow exposure based cytotoxicity studies using microfluidic 
technologies was a better platform for studying nanoparticle-based cell cytotoxicity because the 
continuous-flow technique could prevent the gravitational settling and aggregation of nanoparticles. 
Thus, a homogeneous distribution of nanoparticles could be maintained during exposure time. The 
problem with aggregation and settling of nanoparticles is that it can change the desired nanoparticle 
concentration, hence misrepresenting cytotoxicity. It has been reported in the literature that the 
aggregation of QDs might somehow be related to the cytotoxic effects of QDs [129]. Continuous-flow 
and perfusion of nutrients represent the physiological environment of the cell due to the presence of a 
circulatory system. This mediates entry of fresh cell culture medium while enabling the removal of 
cellular waste and ensuring a constant temperature and pH. Although the morphological changes due 
to QD cytotoxicity were found to be similar under flow and static conditions, cytotoxicity leading to 
apoptosis and deformed cells were found to be more pronounced under static conditions (30%   
cell survival) than compared to that under flow conditions (70% cell survival). The difference in   




of QDs on the surface of the cells. Ultimately, the leading cause for cell cytotoxicity was attributed  
to the release of Cd
2+ ions from the QD core and the generation of reactive oxygen species inside the 
cells [129,130]. 
Investigation of cytotoxicity conducted under a continuous-flow scheme using microfluidics clearly 
demonstrated that the flow exposure conditions significantly affected cell viability. Thus, it is 
important that cytotoxicity studies conducted under static conditions be re-evaluated in terms of how 
the gravitational sedimentation of QDs changes the localized environment of the cell and the relevant 
implications on cell viability.  
7. Summary and Outlook 
This review highlights recent developments in the assimilation of QDs and microfluidic 
technologies onto a single platform to expand the available repertoire of biosensing and bioassay 
applications and to improve assay performance. A variety of QD-based biosensor platforms have 
emerged in recent years that consistently aim at developing systems that provide integrated, on-chip 
analysis systems capable of a wide variety of applications, essentially combining the advantages of 
both nano- and micro-technologies. QDs can be integrated into a MFS on an individual basis or by 
inclusion within other matrices, thereby ensuring immobilization or capture of biomolecular 
recognition elements, which is the basic operating principal for biosensing and bioassay systems. 
It should be understood that the integration of microfluidics for biosensing remains an active area of 
scientific research. Several technological components and even some fundamental concepts are just 
now being developed, prompting continual innovation. Currently, the use of continuous-flow 
microfluidics dominates this developmental stage, and a large majority of available MFSs highlight the 
advantages achieved by implementing this type of system when compared to conventional biosensing 
techniques. The use of droplet-based microfluidics for biosensing applications is not well developed, 
and that of digital microfluidics is virtually nonexistent, suggesting untapped opportunities for further 
development of biosensor platforms. In short, the outlook is promising, and the synergistic use of QDs 
and microfluidics will offer many possibilities.  
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